This page enables investors and potential investors alike to access core management and financial information in compliance with Rule 26 of the AIM Rules for Companies.

For information on the following topics, please click on the links below.

Securities Information
Listed exchanges
Major shareholders

Securities restrictions
There are no restrictions on transfer of AIM securities of Allergy Therapeutics plc (AGY).

If you require further information about Allergy Therapeutics, please contact us.

This website is owned by Allergy Therapeutics plc, and hosted by Emperor Design Consultants Limited.